BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 17937889)

  • 1. [Dendritic cells of mucosa and skin: "recruited for vaccination"].
    Le Borgne M; Dubois B; Kaiserlian D
    Med Sci (Paris); 2007 Oct; 23(10):819-25. PubMed ID: 17937889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.
    Le Borgne M; Etchart N; Goubier A; Lira SA; Sirard JC; van Rooijen N; Caux C; Aït-Yahia S; Vicari A; Kaiserlian D; Dubois B
    Immunity; 2006 Feb; 24(2):191-201. PubMed ID: 16473831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
    Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
    J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells from bench to bedside and back.
    Adema GJ
    Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting dendritic cells for priming cellular immune responses.
    Gogolák P; Réthi B; Hajas G; Rajnavölgyi E
    J Mol Recognit; 2003; 16(5):299-317. PubMed ID: 14523943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells.
    Gaffal E; Schweichel D; Tormo D; Steitz J; Lenz J; Basner-Tschakarjan E; Limmer A; Tüting T
    Eur J Cell Biol; 2007 Dec; 86(11-12):817-26. PubMed ID: 16928407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines.
    Stoecklinger A; Eticha TD; Mesdaghi M; Kissenpfennig A; Malissen B; Thalhamer J; Hammerl P
    J Immunol; 2011 Feb; 186(3):1377-83. PubMed ID: 21187444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
    Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
    Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cells prime IL-17-producing T cells and dampen genital cytotoxic responses following mucosal immunization.
    Hervouet C; Luci C; Rol N; Rousseau D; Kissenpfennig A; Malissen B; Czerkinsky C; Anjuère F
    J Immunol; 2010 May; 184(9):4842-51. PubMed ID: 20351191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.
    Allan RS; Waithman J; Bedoui S; Jones CM; Villadangos JA; Zhan Y; Lew AM; Shortman K; Heath WR; Carbone FR
    Immunity; 2006 Jul; 25(1):153-62. PubMed ID: 16860764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
    Liu Y; Huang H; Chen Z; Zong L; Xiang J
    J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL.
    Cao T; Ueno H; Glaser C; Fay JW; Palucka AK; Banchereau J
    Eur J Immunol; 2007 Sep; 37(9):2657-67. PubMed ID: 17683111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of skin-derived dendritic cells in CD8+ T cell priming following immunization with lentivectors.
    Furmanov K; Elnekave M; Lehmann D; Clausen BE; Kotton DN; Hovav AH
    J Immunol; 2010 May; 184(9):4889-97. PubMed ID: 20357252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration.
    Cumberbatch M; Kimber I
    Immunology; 1992 Feb; 75(2):257-63. PubMed ID: 1551688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directly transfected langerin+ dermal dendritic cells potentiate CD8+ T cell responses following intradermal plasmid DNA immunization.
    Elnekave M; Furmanov K; Nudel I; Arizon M; Clausen BE; Hovav AH
    J Immunol; 2010 Sep; 185(6):3463-71. PubMed ID: 20713888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.
    Neuenhahn M; Busch DH
    Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity.
    Carbone FR; Belz GT; Heath WR
    Trends Immunol; 2004 Dec; 25(12):655-8. PubMed ID: 15530835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically modified dendritic cells in cancer therapy: implications for transfusion medicine.
    Foley R; Tozer R; Wan Y
    Transfus Med Rev; 2001 Oct; 15(4):292-304. PubMed ID: 11668436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.